Calcitonin Gene-Related Peptide (CGRP) and Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Migraine Pathogenesis

Casper Emil Christensen; Messoud Ashina; Faisal Mohammad Amin

doi:10.3390/ph15101189

Calcitonin Gene-Related Peptide (CGRP) and Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Migraine Pathogenesis

Casper Emil Christensen, Messoud Ashina, Faisal Mohammad Amin^*

^*Corresponding author for this work

Abstract

Migraine is a prevalent and debilitating neurologic disorder. Advancements in understanding the underlying pathophysiological mechanisms are spearheading the effort to introduce disease-specific treatment options. In recent years this effort has largely focused on alteration of endogenous neuropeptide signaling, namely the peptides calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase-activating polypeptide (PACAP). Human studies into the pathophysiological underpinnings of CGRP and PACAP in migraine are manifold and here we review the works investigating these neuropeptides in patients suffering from migraine in order to elucidate the background for developing new treatment options for this vastly disabling disorder.

Original language	English
Article number	1189
Journal	Pharmaceuticals (Basel, Switzerland)
Volume	15
Issue number	10
ISSN	1424-8247
DOIs	https://doi.org/10.3390/ph15101189
Publication status	Published - 27 Sep 2022

Access to Document

10.3390/ph15101189

Cite this

@article{4868cc82fb3d4e90bda52450424f1b68,

title = "Calcitonin Gene-Related Peptide (CGRP) and Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Migraine Pathogenesis",

abstract = "Migraine is a prevalent and debilitating neurologic disorder. Advancements in understanding the underlying pathophysiological mechanisms are spearheading the effort to introduce disease-specific treatment options. In recent years this effort has largely focused on alteration of endogenous neuropeptide signaling, namely the peptides calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase-activating polypeptide (PACAP). Human studies into the pathophysiological underpinnings of CGRP and PACAP in migraine are manifold and here we review the works investigating these neuropeptides in patients suffering from migraine in order to elucidate the background for developing new treatment options for this vastly disabling disorder.",

author = "Christensen, {Casper Emil} and Messoud Ashina and Amin, {Faisal Mohammad}",

year = "2022",

month = sep,

day = "27",

doi = "10.3390/ph15101189",

language = "English",

volume = "15",

journal = "Pharmaceuticals",

issn = "1424-8247",

publisher = "M D P I AG",

number = "10",

}

TY - JOUR

T1 - Calcitonin Gene-Related Peptide (CGRP) and Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Migraine Pathogenesis

AU - Christensen, Casper Emil

AU - Ashina, Messoud

AU - Amin, Faisal Mohammad

PY - 2022/9/27

Y1 - 2022/9/27

N2 - Migraine is a prevalent and debilitating neurologic disorder. Advancements in understanding the underlying pathophysiological mechanisms are spearheading the effort to introduce disease-specific treatment options. In recent years this effort has largely focused on alteration of endogenous neuropeptide signaling, namely the peptides calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase-activating polypeptide (PACAP). Human studies into the pathophysiological underpinnings of CGRP and PACAP in migraine are manifold and here we review the works investigating these neuropeptides in patients suffering from migraine in order to elucidate the background for developing new treatment options for this vastly disabling disorder.

AB - Migraine is a prevalent and debilitating neurologic disorder. Advancements in understanding the underlying pathophysiological mechanisms are spearheading the effort to introduce disease-specific treatment options. In recent years this effort has largely focused on alteration of endogenous neuropeptide signaling, namely the peptides calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase-activating polypeptide (PACAP). Human studies into the pathophysiological underpinnings of CGRP and PACAP in migraine are manifold and here we review the works investigating these neuropeptides in patients suffering from migraine in order to elucidate the background for developing new treatment options for this vastly disabling disorder.

UR - http://www.scopus.com/inward/record.url?scp=85140791064&partnerID=8YFLogxK

U2 - 10.3390/ph15101189

DO - 10.3390/ph15101189

M3 - Review

C2 - 36297301

VL - 15

JO - Pharmaceuticals

JF - Pharmaceuticals

SN - 1424-8247

IS - 10

M1 - 1189

ER -

Calcitonin Gene-Related Peptide (CGRP) and Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Migraine Pathogenesis

Abstract

Access to Document

Other files and links

Fingerprint

Cite this